AACR Annual Meeting 2024: A Global View on Cancer
International award and grant recipients from the Annual Meeting 2024 talk about defeating cancer globally.
International award and grant recipients from the Annual Meeting 2024 talk about defeating cancer globally.
The editors of the 10 AACR journals have selected a handful of must-read articles from the July issues. The...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
As the first AACR Annual Meeting held in person after the pandemic was coming to a close, the last...
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...
This month’s selection of studies picked by the editors of the AACR journals includes a new bispecific antibody for...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...